NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Seagen Inc.
Sellas Life Sciences Group
Alliance Foundation Trials, LLC.
Merck Sharp & Dohme LLC
NYU Langone Health
Incyte Corporation
Incyte Corporation
Seoul National University Hospital